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The a2d-1 protein is an auxiliary subunit of voltage-gated calcium channels, critical for neurotransmitter
release. It is upregulated in dorsal root ganglion (DRG) neurons following sensory nerve injury, and is also
the therapeutic target of the gabapentinoid drugs, which are efﬁcacious in both experimental and human
neuropathic pain conditions. a2d-1 has 3 spliced regions: A, B, and C. A and C are cassette exons, whereas
B is introduced via an alternative 30 splice acceptor site. Here we have examined the presence of a2d-1
splice variants in DRG neurons, and have found that although the main a2d-1 splice variant in DRG is
the same as that in brain (a2d-1 DA+B+C), there is also another a2d-1 splice variant (DA+BDC), which
is expressed in DRG neurons and is differentially upregulated compared to the main DRG splice variant
a2d-1 DA+B+C following spinal nerve ligation. Furthermore, this differential upregulation occurs prefer-
entially in a small nonmyelinated DRG neuron fraction, obtained by density gradient separation. The
a2d-1 DA+BDC splice variant supports CaV2 calcium currents with unaltered properties compared to
a2d-1 DA+B+C, but shows a signiﬁcantly reduced afﬁnity for gabapentin. This variant could therefore play
a role in determining the efﬁcacy of gabapentin in neuropathic pain.
 2013 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.1. Introduction
Voltage-gated Ca2+ channels of the CaV1 and CaV2 families con-
tain 3 subunits: the pore-forming a1 subunit, together with 2 aux-
iliary subunits, b and a2d, both of which increase the functional
expression of the channels [4,11,13,20,21]. The a2d subunits are
each the product of a single gene (CACNA2D1-4), encoding an a2d
preprotein, which is posttranslationally processed into a2 and d
[22]. We have recently shown that a2d subunits can form glycosyl-
phosphatidylinositol-anchored proteins [19], which are constitu-
tively endocytosed and reinserted into the plasma membrane via
the recycling endosomes [5,48]. We have identiﬁed that the mech-
anism whereby a2d-1 and -2 subunits enhance plasma-membrane
expression of calcium channels involves the metal ion-dependent
adhesion site (MIDAS) motif in their von Willebrand factor A(VWA) domain [12,31], and it is also important for the enhance-
ment of presynaptic vesicular release [31].
The a2d-1 subunit has a widespread distribution; both mRNA
and protein are found in neuronal tissue, heart, skeletal, and
smooth muscle [3]. In dorsal root ganglion (DRG) neurons, a2d-1
is the main a2d subunit expressed [5,16,36]. The a2d-1 protein is
upregulated following various types of peripheral nerve injury
[5,39,49], and this upregulation is essential for the rapid
development of the subsequent behavioural mechanical hypersen-
sitivity seen in animal models [41]. By contrast, CaV2.2 mRNA and
protein are not reported to be consistently upregulated following
sensory nerve damage [1,36,49], suggesting that upregulated
a2d-1 protein enhances CaV2.2 trafﬁcking and presynaptic
function.
The a2d-1 and a2d-2 subunits bind to the gabapentinoid drugs,
gabapentin and pregabalin. These were developed as antiepileptic
drugs and are also widely used in the treatment of various forms of
neuropathic pain [46]. The a2d-1 subunit has been shown to repre-
sent the target for these drugs in the alleviation of hyperalgesia in
experimental models of neuropathic pain [24]. We have found that
gabapentin and pregabalin reduce the trafﬁcking of a2d subunits
both in vitro and in vivo [5,30,48], which is likely to represent
one of their main mechanisms of action. Furthermore, a2d-1 has
been reported to interact with thrombospondins, a family of
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155 (2014) 522–533 523extracellular matrix proteins, and this may inﬂuence its trafﬁcking
as well as the effect of gabapentinoid drugs [23].
Alternatively spliced isoforms of a2d-1 in different tissues have
been observed previously [10,22]. It was reported that the mouse
cacna2d1 gene has 3 alternatively spliced regions (A, B, and C),
and 5 splice variants were identiﬁed [3] (Fig. 1A). In the present
study we have examined the hypothesis that there may be differ-
ential upregulation of speciﬁc splice variants of a2d-1 following
peripheral nerve damage, and that this might potentially contrib-
ute to either the state dependency [14,25] or to limiting the re-
sponse to gabapentinoids, as these drugs are found to have
variable efﬁcacy in patients, with number-needed-to-treat values
of about 4–5 [37,38].
2. Methods
2.1. Molecular biology and heterologous expression of cDNAs
Rat a2d-1 (M86621.3) [47], which encodes the main brain splice
variant DA+B+C, was used as the starting point for assembly of the
a2d-1 splice variants used in this study. All mutations were made
by standard molecular biological techniques, and veriﬁed by DNA
sequencing. Other calcium channel complementary DNAs (cDNAs)
used were rat CaV2.1 (M64373), rabbit CaV2.2 (D14157), and rat
b1b [47]. The cDNAs were cloned into the pMT2 vector for expres-
sion. For heterologous expression, tsA-201 cells were transfected
with the cDNA combinations stated. The cDNA for green ﬂuores-
cent protein (mut3 GFP) [17] was also included to identify trans-
fected cells from which electrophysiological recordings were
made. Transfection was performed as described previously [40].
In control experiments where a2dwas omitted, the ratio was made
up with empty vector.
2.2. Isolation of detergent-resistant membranes (DRMs)
This procedure was performed as previously described
[19,32]. Brieﬂy, conﬂuent cells from 6 175-cm2 ﬂasks (72 hours
after transfection), or pelleted homogenate from rat whole brain,
were resuspended in 1.5 mL 2-(N-morpholino)ethanesulfonic
acid (MES)-buffered saline containing 1% (2% for brain tissue)
Triton X-100 (Perbio, Tattenhall, Cheshire, UK) and left on ice
for 1 hour. After the addition of an equal volume of 90% (w/v)
sucrose, the sample was overlaid with a 10-mL discontinuous
sucrose gradient and centrifuged at 140,000  g for 18 hours
at 4C. One-mL fractions of the gradient were harvested from
the top to the bottom of the tube, washed free of sucrose by
dilution in MES-buffered saline and subsequent centrifugation.
The detergent-resistant membranes (DRMs) were prepared from
pooled fractions 4, 5, and 6. The resulting pellet was resus-
pended in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) 10 mM pH 7.4 and complete protease inhibitor cocktail
(Roche Diagnostics GmbH, Mannheim, Germany). The isolated
DRM fractions were collected for Western blot analysis and used
in the 3H-gabapentin binding assay.
2.3. Immunoblotting
Western blotting was performed as described previously [40].
The following primary antibodies were used: anti-a2-1 (1:1000;
mouse monoclonal, Sigma-Aldrich, St. Louis, MO, USA) and anti-
ﬂotillin-1 (1:2000; mouse monoclonal, BD Biosciences, Franklin
Lakes, NJ, USA). The secondary antibody used was goat anti-mouse
coupled to horseradish peroxidase (Bio-Rad Laboratories, Inc.,
Hercules, CA, USA). Protein bands were quantiﬁed using Image J
software (rsb.info.nih.gov). All a2d-1 splice variant expression lev-els were corrected for background and normalized to DA+B+C pro-
tein expression on the same gel.
2.4. 3H gabapentin binding assay
Binding of 3H-gabapentin to DRM fractions from transfected
tsA-201 cells was carried out in a ﬁnal volume of 250 lL at room
temperature for 45 minutes. DRMs (4 lg protein per tube) were
incubated with various concentrations of 3H-gabapentin [45]
(30–50 Ci/mmol, American Radiolabeled Chemicals, St. Louis, MO,
USA) in 10 mM HEPES/KOH pH 7.4, then rapidly ﬁltered through
glass ﬁbre (B grade, Whatman) ﬁlters presoaked with 0.3% polyeth-
yleneimine. Filters were washed 3 times with 3 mL ice-cold
100 mM Tris/HCl pH 7.4 and counted in a scintillation counter.
Concentrations of 3H-gabapentin >10 nM were achieved by adding
nonradioactive gabapentin and correcting the speciﬁc binding by
the dilution factor [12]. Nonspeciﬁc binding was determined in
the presence of 100 lM nonradioactive gabapentin. Data points
were determined in triplicate, and data were analysed by ﬁtting
speciﬁc binding to the equation for a rectangular hyperbola.
2.5. Spinal nerve ligation (SNL)
A total of 17 male Sprague-Dawley rats (Central Biological Ser-
vices, University College London, London, UK) weighing 130–150 g
at time of surgery were employed for this study. All experimental
procedures were approved by the UK Home Ofﬁce and followed the
guidelines of the International Association for the Study of Pain
[51]. Selective spinal nerve ligation (SNL) surgery was conducted
as previously described [34]. Brieﬂy, the left L5 and L6 spinal
nerves were isolated and tightly ligated with 6-0 silk thread under
isoﬂurane anaesthesia (50% O2: 50% N2O). Haemostasis was con-
ﬁrmed and the wound was sutured. After surgery the animals were
allowed to recover and housed at a maximum of 5 per cage. Food
and water were available ad libitum. The foot posture and general
behaviour of the operated rats were monitored throughout the
postoperative period, and the development of mechanical hyper-
sensitivity was conﬁrmed at 7 days post surgery in the affected
limb ipsilateral to the ligation, as previously described [5].
2.6. Enrichment of small and large DRG neurons using density gradient
centrifugation
In order to obtain sufﬁcient material, both L5 and L6 DRG were
extracted from the ipsilateral and contralateral sides of 2 rats,
either naïve animals or 7 days after SNL. Nerve roots were trimmed
and the isolated ganglia were incubated in 5 U/mL of collagenase
(Sigma-Aldrich) in 2 mL of Hanks balanced saline solution in a
shaking water bath at 37C for 30 minutes, and then triturated.
The cell suspension was sedimented at 4C for 5 minutes at 200
 g. The pellet was resuspended in culture medium composed of
Dulbecco’s Modiﬁed Eagle’s Medium: Nutrient Mixture F-12 (Gib-
co, Invitrogen, Life Technologies, Grand Island, NY, USA), penicillin
(100 U/mL), streptomycin (100 lg/mL), L-glutamine, (2 mM), nerve
growth factor (100 ng/mL, Sigma-Aldrich), and 10% foetal calf ser-
um. Four mL of DRG neurons in culture medium was ﬁltered
through a 100-lm cell strainer (BD Biosciences) and layered onto
5 mL of a solution of 40% Ficoll (Histopaque-1077, Sigma-Aldrich)
and 60% phosphate-buffered saline containing 4.2 mM NaHCO3.
The ﬁnal pH was adjusted to 7.3–7.4 with HCl. The preparation
was centrifuged at 100  g for 15 minutes at 4C, and DRG neurons
were separated according to their size into a low-density fraction
(LDF) and a high-density fraction (HDF) [28]. The 2 fractions
obtained were diluted to 10 mL with culture medium and then
centrifuged at 200  g for 5 minutes at 4C. The LDF and HDF pel-
lets, enriched in viable small and large neurons, respectively, were
Fig. 1. Distribution of different a2d-1 splice variants in rat tissue. (A) Diagram of possible splice variants of a2d-1, showing arrangement of exons within the region of
alternative splicing, and position of cassette exon 18a encoding A (white), alternative spliced region B (black), and cassette exon 23 encoding C (dark grey), data obtained from
Ensembl database, gene IDs ENSG00000153956 (human), ENSMUSG00000040118 (mouse), and ENSRNOG00000033531 (rat). (B) Identiﬁcation of a2d-1 splice variants using
outer primer pairs. Bands were recovered from the gel and sequenced, to verify identiﬁcation. Lanes 1–4 were ampliﬁed from plasmids, lanes 5–8 were ampliﬁed from the
tissues stated, lane 9 is the water control, and lane L is the size ladder. Samples were run on 2%MetaPhor Agarose Gel (Cambrex Bio Science Rockland, Inc., Rockland, ME, USA)
in Tris Acetate Ethylenediaminetetraacetic acid, 100V. (C) DADBDC is the most abundant a2d-1 splice variant in rat heart. Representative electropherogram of capillary
electrophoresis/laser-induced ﬂuorescence with polymerase chain reaction (PCR) products derived from rat heart. Reverse-transcription PCR was performed for 30 cycles on
100 ng of total RNA equivalent. a2d-1 transcript products were separated by size along the x-axis: DADBDC (345 bp), DA+BDC (360 bp), DADB+C (366 bp), DA+B+C (381 bp),
+ADBDC (402 bp), +ADB+C (423 bp), +A+B+C (438 bp). The y-axis indicates the ﬂuorescence signal peak height, which corresponds to the expression level of the respective
splice variant. (D) Diagram of domains in a2d-1 to show the approximate positions of the 2 domains with homology to bacterial chemosensory domains (CSDs), with respect
to the von Willebrand factor A domain and to regions A, B, and C. (E) Structure prediction for the bacterial chemosensor-like domains of a2d-1. The sequence of a2d-1
including the 2 predicted bacterial chemosensory domains (starting at amino acid 491[Asp-Val-Ser-Leu . . .]-945 (. . . Leu-Glu-Ala, which is the end of a2-1) was submitted to
Phyre2 [33] for structure prediction (http://www.sbg.bio.ic.ac.uk/phyre2). The amino acid numbering includes the N-terminal signal sequence of a2d-1. Region I (amino
acids 491–607) was predicted with99% conﬁdence, and modelled on a number of bacterial CSDs, including the extracellular domain of the Bacillus subtilis CSD (mmhk1s-z2)
and the putative sensory box/ggdef protein from Vibrio parahaemolyticus. Region II (amino acids 687–886) was modelled with a predicted 98% conﬁdence on a separate
subset of CSDs, including the C4-dicarboxylate transport sensor protein dctb, and the mcp_n and cache domains of methyl-2 accepting chemotaxis protein from Vibrio
cholerae. The regions between domains I and II and beyond II are not modelled with high conﬁdence. The approximate positions of the two spliced regions B and C are
indicated. They are both likely to be in exposed loops, B being within the ﬁrst chemosensory domain, and C being between the 2 domains. A is not present in this model.
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155 (2014) 522–533 525obtained and immediately used for RNA extraction, or plated on
13-mm-diameter poly-D-lysine-coated (10 mg/mL; Sigma-Aldrich)
glass coverslips. Cells were incubated at 37C (95% air, 5% CO2), and
observed in bright ﬁeld after 2–5 hours to measure the density and
diameter of the neurons in each fraction. Only phase-bright cells
with a typical DRG morphology (large, clear nucleus with promi-
nent nucleolus) were considered for statistical analysis. Larger cells
were often slightly elliptical in cross-section, and the diameter was
taken as the mean of the major and minor axes. Quantiﬁcation of
neuroﬁlament-200 (NF-200) mRNA, a well-established marker for
medium to large neurons [26,29] was employed to conﬁrm the
successful separation of neuronal fractions.
2.7. Quantiﬁcation of splice variants and NF-200 by quantitative
polymerase chain reaction (PCR) and capillary electrophoresis (CE)
RNA isolation and reverse-transcription polymerase chain reac-
tion (RT-PCR) was carried out as follows. Total RNA was extracted
from individual L4 or L5 pulverized frozen DRG 7 days after SNL or
sham surgery, and pelleted LDF and HDF after density gradient
centrifugation. RNA was isolated using the RNeasy Protect Mini
Kit (Qiagen, GmbH, Hilden, Germany). RNA concentrations and
purity were determined spectrophotometrically. RT was per-
formed on 1 lg of total RNA using Superscript III reverse transcrip-
tase (Invitrogen, Carlsbad CA, USA), using random hexamer
primers (Promega, Madison WI, USA) and RNaseOUT (Invitrogen).
In order to quantify the a2d-1 splice variant expression pattern
in rat tissue (Fig. 1) and in DRG neurons following SNL, gene-
speciﬁc primers for rat a2d-1 (Euroﬁns MWG Operon, Ebersberg,
Germany) were designed ﬂanking all 3 splicing sites. For the
analysis of the a2d-1 splice variant expression pattern in LDF and
HDF, gene-speciﬁc primers for NF-200 and a2d-1, ﬂanking only
region C, were designed. TATA-box binding protein (TBP) was
co-ampliﬁed in each reaction and served as an internal control in
all experiments. The primer combinations resulted in the following
target-speciﬁc PCR products: 145 bp (TBP), 360 bp (a2d-1; splice
variant DA+BDC), 381 bp (a2d-1; splice variant DA+B+C), 101 bp
(NF-200), 154 bp (a2d-1; splice variant lacking region C), and
175 bp (a2d-1; splice variant with region C). Either forward or re-
verse primers were labelled with 6-carboxyﬂuorescein. PCR was
performed on 100 ng (whole DRG), 8 ng (for a2d-1 in LDF and
HDF), and 3 ng (for NF-200 in LDF and HDF) of total RNA equiva-
lent, with Taq DNA Polymerase (Bioline Ltd., London, UK) in a total
of 20 lL reaction volume. Thermal cycling was conducted with the
following conditions: denaturation at 95C for 2 minutes; 27, 28, or
29 cycles of 95C for 30 seconds, 65C for 30 seconds, and 72C for
40 seconds. The following PCR primers were used: rat a2d-1
(NM_012919), 50-CGATCCTAATGGTTATGTCTTACTGC-30 (forward)
and 50-TCAAAATTGTCTGGCTTCAGGGTTTCT-30 (reverse) ﬂanking
all 3 splicing sites; a2d-1_C 50-GTCAATGGCACAGATTACAG-30
(forward), a2d-1_C 50-GTGCTATGAAAGTGTAGCCAG-30 (reverse)
ﬂanking only region C; rat NF-200 (NM_012607) 50-AAAGTG
AACACGGATGCTATG C-30 (forward), NF-200 50-GTGCTTTTCAGT
GCCTCCAAC-3 0 (reverse); rat TBP (NM_001004198),
5 0-GGATTGTACCACAGCTCCAAAATAT-3 0 (forward), 5 0-
CGTGGCTCTCTTATTCTCATGATG-30 (reverse). Primers were
designed either manually or using the open-source software Pri-
mer3. The techniques were optimized in a series of preliminary
experiments for cycle number and starting quantity to ensure
points of measurement were acquired during the linear phase of
ampliﬁcation (Supplementary Fig. 1, and data not shown).
Capillary electrophoresis (CE) was carried out following dilution
(1:20 for a2d-1 primers ﬂanking all splice regions; 1:5 for NF-200)
with deionized water of aliquots of RT-PCR products, and further
analysed by laser-induced ﬂuorescence (LIF). A detailed description
and validation of the CE/LIF technique used for quantitative analy-sis of RT-PCR products was reported previously [43]. One lL of
sample was diluted with 12 lL HiDi-Formamide (Applied Biosys-
tems, Foster City CA, USA), and 0.5 lL of GeneScan 400HD ROX Size
Standard (Applied Biosystems). Ampliﬁed PCR products were sep-
arated on an ABI 3100 Avant Genetic Analyzer (Applied Biosys-
tems) running a 50-cm capillary with 3100 POP-6 polymer
(Applied Biosystems). Each sample was injected in triplicate from
separate wells on the plate. The ampliﬁed products were sized
and quantiﬁed in GeneMapper v3.5 software using the Local South-
ern method. This analysis method was chosen for its reciprocal
relationship between fragment size and mobility.
The relative abundance of mRNA was determined as the ratio of
integrated peak area for each PCR product relative to that of co-
ampliﬁed TBP in order to allow a direct comparison between differ-
ent preparations. Then, data from the ipsilateral side were normal-
ized to their respective contralateral side. The percentage of the
total transcript represented by the minor DRG isoform (DA+BDC)
was calculated as 100⁄ paDA+BDC/(paDA+B+C+paDA+BDC) [44]. Data
were analysed using Microsoft Excel (Microsoft Corporation, Red-
mond, WA, USA) and SPSS statistical software (SPSS Inc, Chicago
IL, USA) or GraphPad Prism 4 (GraphPad Software, San Diego, CA,
USA). Statistical signiﬁcance was determined using the nonpara-
metricMann-Whitney U test and one-way analysis of variance with
a suitable post hoc analysis. P values <0.05 were considered as sta-
tistically signiﬁcant. All data are presented as mean ± SEM for the
indicated number of experiments.
2.8. Electrophysiology
Calcium channel expression in tsA-201 cells was investigated
by whole-cell patch clamp recording, essentially as described pre-
viously [7], using an Axopatch 1D ampliﬁer (Axon Instruments,
Burlingame, CA, USA). Recordings were made 2 days after transfec-
tion. Pipettes of resistance 2–4 MX were used, and the internal
(pipette) and external solutions and recording techniques were
similar to those previously described [30]. The patch pipette solu-
tion contained (in mM): Cs-aspartate, 140; ethylene glycol tetra-
acetic acid, 5; MgCl2, 2; CaCl2, 0.1; K2ATP, 2; HEPES, 20; pH 7.2,
310 mOsm with sucrose. The external solution for recording Ba2+
currents contained (in mM): tetraethylammonium Br, 160; KCl,
3; NaHCO3, 1.0; MgCl2, 1.0; HEPES, 10; glucose, 4; BaCl2, 1, pH
7.4, 320 mOsm with sucrose. Data were ﬁltered at 1–2 kHz and
digitized at 5–10 kHz. Current records were subjected to leak and
residual capacitance current subtraction (P/8 protocol). Analysis
was performed using Pclamp 9 (Molecular Devices, Sunnyvale,
CA, USA) and Origin 7 (Microcal Origin, Northampton, MA, USA).3. Results
3.1. Distribution of different splice variants of a2d-1 in rat tissue
Splice variants of a2d-1 containing the 3 alternatively spliced
regions (A, B, and C) were identiﬁed previously in mouse tissue
[3]. In that study it was reported that regions A and B were part
of the same exon, with alternative 30 splice acceptor sites, which
spliced region A in or out [3]. However, the currently available hu-
man, mouse, and rat genomic sequences from Ensembl,
ENSG00000153956 (human), ENSMUSG00000040118 (mouse),
and ENSRNOG00000033531 (rat), indicate that regions A and B
are in separate exons, with region A in rat being encoded by exon
18a, and B representing an alternative 30 splice acceptor site (start
site) of exon 19. A diagram of potential splice variants is given in
Fig. 1A.
The following cDNAs were assembled by standard molecular
biological techniques in the rat a2d-1 backbone: +A+B+C,
Fig. 2. Analysis of the level of expression and gabapentin binding properties of the
a2d-1 splice variants. (A) Representative Western blots showing that the level of
protein expression in detergent-resistant membrane (DRM) preparations is similar
between all the a2d-1 splice variants analysed. (B) No signiﬁcant difference in mean
normalized immunoreactivity of the a2d-1 bands was observed after image analysis
(+A+B+C, n = 3; +A+BDC, n = 3; DADB+C, n = 3, DA+B+C, n = 10; DA+BDC, n = 4, and
DADBDC, n = 3). Bands were normalized to the main brain splice variant DA+B+C in
every experiment. Error bars represent SEM. Statistical analysis was performed
using one-way analysis of variance (ANOVA) and Bonferroni post hoc analysis. (C)
Measurement of the afﬁnity of 3H-gabapentin binding sites in DRM fractions for 3
a2d-1 splice variants. The curves show the mean data obtained for a2d-1 DA+B+C
(j, ﬁtted with solid line), DA+BDC (D, ﬁtted with dotted line) and DADBDC (s,
ﬁtted with dashed line) binding to 3H-gabapentin, ﬁtted using the Hill-Langmuir
equation. Data were normalized to each mean Bmax to illustrate the difference in KD
values. (D) The mean KD for all the splice variants tested (+A+B+C, n = 5; +A+BDC,
n = 5; DADB+C, n = 5; DA+B+C, n = 12; DA+BDC, n = 8, and DADBDC, n = 5). Mean
values for KD were calculated from ﬁtting individual experiments, each carried out
in triplicate. The bar chart shows the reduced afﬁnity of a2d-1 DA+BDC (dark grey
bar) and DADBDC (black bar) compared to the predominant brain and dorsal root
ganglion splice variant DA+B+C (white bar). Error bars represent SEM. Statistical
analyses were performed using one-way ANOVA, with Bonferroni post hoc analysis:
⁄P < 0.05, ⁄⁄⁄P < 0.001. The Bmax values were not altered, being (in pmol/mg protein)
15.6 ± 2.6 for +A+B+C; 12.1 ± 0.5 for +A+BDC; 11.8 ± 1.6 for DADB+C; 15.7 ± 2.9 for
DA+B+C; 17.0 ± 4.8 for DA+BDC; and 14.7 ± 2.7 for DADBDC.
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gave rise to products of the expected size with the PCR primers
used in this study (Fig. 1B and data not shown). We then examined
their distribution in adult rat tissues. DADBDC was found to be the
main splice variant in rat heart, but a number of other splice vari-
ants were also identiﬁed by the much more sensitive CE/LIF, dem-
onstrating that this method can be used for identifying and
quantifying a2d-1 splice variants (Fig. 1B, C). We found +A+BDC
in skeletal muscle and DA+B+C in cerebral cortex (Fig. 1B), as
shown previously for mouse tissues [3]. We also found the same
brain splice variant, DA+B+C, in DRG (Fig. 1B).
3.2. Location of the spliced regions within a2d-1
The a2d subunits contain 2 domains with homology to bacte-
rial extracellular chemosensory domains (CSDs) or Cache domains
[2], which are downstream of the VWA domain. Bacterial extracel-
lular CSDs bind a variety of nutrients and are generally associated
with an intracellular histidine kinase signalling complex [15]. The
plant ethylene receptor ETR1 is also a member of this family [15].
In a2d-1, the ﬁrst of these CSDs is situated between amino acids
491–607 [21]. Fig. 1D gives the approximate locations of the
spliced regions, and Fig. 1E [33] illustrates a homology model of
the 2 CSDs, showing that regions B and C are situated within a
loop in the ﬁrst CSD of rat a2d-1 (I), and in the linker between
CSD I and II, respectively. The model in Fig. 1E was generated
using a sequence from which region A was absent, but A would
be situated just upstream of region B. It is possible that within
a2d subunits, these domains might be important for their ability
to bind small ligands, including gabapentin [21].
3.3. Determination of 3H-gabapentin binding afﬁnity for a2d-1 splice
variants
We then examined whether there were differences in 3H-gaba-
pentin binding afﬁnity between the different a2d-1 splice variants
(Fig. 2). All determinations were performed on concentrated DRM
fractions following expression in tsA-201 cells, since we have
shown previously that there is a large increase in apparent afﬁnity
of both a2d-1 and a2d-2 for 3H-gabapentin in DRMs [18,30].
To ensure that the radioligand binding experiments were not
inﬂuenced by differential expression of a2d-1 protein between
the different splice variants used, the relative expression level in
DRMs of each splice variant was analysed by Western blot. All
splice variants partitioned similarly into DRM fractions, and their
level of expression was also found to be similar (Fig. 2A, B). We
found that bothDADBDC (one of the splice variants found in heart)
and DA+BDC showed signiﬁcantly lower afﬁnity for 3H-gabapentin
(KD values of 211 and 153 nM, respectively), compared to the ma-
jor brain and DRG splice variant DA+B+C (Fig. 2C, D). Both these
splice variants with lower afﬁnity lacked region C, whereas all
the splice variants containing region C, including DA+B+C, showed
a higher afﬁnity for 3H-gabapentin, with KD values between 80 and
102 nM (Fig. 2C, D). Thus, there was a nearly 3-fold difference in
afﬁnity between the splice variants with the highest and lowest
3H-gabapentin binding afﬁnities. In contrast, all splice variants
showed similar Bmax values, indicating that the number of binding
sites was not affected (see legend to Fig. 2).
3.4. Do novel splice variants of a2d-1 become expressed in DRG
following SNL?
Gabapentinoid drugs are used to treat neuropathic pain, so we
wondered whether there were changes in splice variant expression
in DRG following SNL, which could potentially inﬂuence the efﬁ-
Fig. 3. The effect of spinal nerve ligation (SNL) on mRNA levels of the a2d-1 splice variants. (A, B) Representative electropherograms of capillary electrophoresis/laser-induced
ﬂuorescence with polymerase chain reaction products derived from L5 dorsal root ganglia (DRG) 7 days after SNL. Transcript products were separated by size along the x-axis.
The y-axis indicates the ﬂuorescence signal peak height, which corresponds to the expression level of the respective splice variant. mRNA levels of DA+B+C and DA+BDC are
higher in the side ipsilateral to SNL (B) than in the contralateral side (A). Note that the expression of the housekeeping gene (TATA-box binding protein) remains at a constant
level on both sides. (C) SNL (7 days) leads to increased expression of the major a2d-1 (DA+B+C) splice variant in L5 DRG. Data are expressed as percentage of relative peak
areas of the ipsilateral side normalized to the respective contralateral side. The relative increase is shown in L4 DRG from sham-operated rats (black bar, n = 6), L4 DRG from
L5/L6 SNL rats (white bar, n = 11), L5 DRG from sham-operated rats (grey bar, n = 6), and L5 DRG after SNL (cross-hatched bar, n = 7). There was no signiﬁcant difference in L4
DRG between SNL and sham-operated animals. Error bars represent SEM. Analysis of variance (ANOVA), F = 9.012, P < 0.0001, and Gabriel post hoc analysis: ⁄⁄P < 0.01. (D) A
pronounced upregulation of the a2d-1 splice variant DA+BDC was observed in ipsilateral L5 DRG 7 days after SNL. Data are expressed as percentage of relative peak areas of
the ipsilateral side normalized to the respective contralateral side. The relative increase is shown in L4 DRG from sham-operated rats (black bar, n = 6), L4 DRG from SNL rats
(white bar, n = 11), L5 DRG from sham-operated animals (grey bar, n = 6) and L5 DRG after SNL (cross-hatched bar, n = 7). Although DA+BDC mRNA levels are 2.4-fold higher
in SNL L4 compared to L4 sham-operated animals, this was not statistically signiﬁcant (P = 0.814). Error bars represent SEM. ANOVA, F = 11.12, P < 0.0001, and Gabriel post
hoc analysis: ⁄⁄⁄P = 0.001. (E) Comparison of the percentage of total transcript represented by DA+BDC splice variant in DRG ipsilateral to SNL, in L4 from sham-operated rats
(black bar, n = 6), L4 DRG from SNL rats (white bar, n = 11), L5 DRG from sham-operated animals (grey bar, n = 4), and L5 DRG after SNL (cross-hatched bar, n = 8). The data
show the pronounced shift in favour of the short splice variant in L5 after SNL. Data are expressed as percentage of relative peak areas for DA+BDC mRNA transcripts
normalized to the sum of DA+B+C and DA+BDC peak areas. Error bars represent SEM. ANOVA, F = 9.39, P = 0.000, and Gabriel post hoc analysis: ⁄⁄P < 0.01, ⁄⁄⁄P < 0.001.
B. Lana et al. / PAIN

155 (2014) 522–533 527
528 B. Lana et al. / PAIN

155 (2014) 522–533cacy of these drugs. We chose 7 days after SNL as the time point for
our analyses because we found previously that the increase in a2d-
1 mRNA was not signiﬁcantly different between 7 and 14 days
after SNL, and we also noted less variability in the increase in
a2d-1 mRNA at 7 than at 14 days [5].
In order to detect and quantify anyminora2d-1 splice variants in
DRG,we used CE/LIF, and conﬁrmed the presence of themajor splice
variant DA+B+C both in unaffected contralateral DRG (Fig. 3A), and
in ligatedDRG after SNL (Fig. 3B). The relative abundance ofDA+B+C
mRNA was quantiﬁed by CE/LIF after 27 cycles of RT-PCR (Fig. 3C).
The DA+B+C-transcript level in ligated L5 showed a 3.6-fold in-
crease, compared to the contralateral side. It was also signiﬁcantly
higher in L5 DRG following SNL, compared to L5 sham-operated ani-
mals, and compared to L4 SNLDRG and L4DRG from sham-operated
rats. Therewasno signiﬁcant difference ina2d-1 levels in L4DRGbe-
tween SNL and sham-operated animals (Fig. 3C).
Surprisingly, we also observed a novel splice variant in DRG neu-
rons, DA+BDC a2d-1, which was particularly evident following the
upregulation of a2d-1 mRNA that occurs after L5/L6 SNL (Fig. 3B).
DA+BDC was identiﬁed in DRG both by DNA sequencing following
agarose gel separation (unpublished results), and by the size of the
product on CE/LIF after RT-PCR (Fig. 3A, B). The mRNA level of the
DA+BDC splice variant was quantiﬁed by CE/LIF after 29 cycles of
RT-PCR (Fig. 3D). The expression level of DA+BDC was found to be
10 times higher (1083%) on the ipsilateral side, compared to the
respective contralateral side in L5 DRG. Moreover, DA+BDC mRNA
levels were signiﬁcantly higher compared to L5 sham-operated ani-
mals, and L4 SNL and sham-operated rats. AlthoughDA+BDCmRNA
levelswere 2.4-fold higher in SNL L4 compared to L4 sham-operated
animals, this was not statistically signiﬁcant (P = 0.814).
Thus, the proportion of DA+B+C was signiﬁcantly increased in
L5, ipsilateral to SNL compared to sham-operated L5, but this
was not the case for L4, which was not ligated. The DA+BDC splice
variant represented 5.1 ± 0.5% of the total a2d-1 mRNA in sham-
operated L5, and 8.4 ± 0.4% in SNL L5 DRG (Fig. 3E).
3.5. The relative abundance of DA+B+C and DA+BDC in different DRG
classes
DRG neurons are heterogeneous in morphology and the size of
their somata relates to different functional subtypes. DRG with
small and medium-sized somata form mainly nonmyelinated C ﬁ-
bres and myelinated Ad ﬁbres, which conduct pain sensation,
whereas nonnociceptive Ab ﬁbres have larger somata [35]. a2d-1
is expressed in every sub-type of DRG neuron [5], but to date,
the distribution of a2d-1 splice variants in DRG subpopulations is
unknown. For the most prevalent DRG calcium channel a1 subunit,
CaV2.2, it has been found that there is a differential distribution of a
particular splice variant in small DRG neurons [1,6], and this splice
variant is downregulated following SNL in rats [1]. Therefore, we
wished to determine whether there was differential distribution
in small and large DRG neurons of the a2d-1 DA+BDC splice vari-
ant, which showed reduced gabapentin binding afﬁnity and a more
pronounced upregulation following SNL, compared to the predom-
inant a2d-1 splice variant DA+B+C.
To obtain populations enriched with small or large neurons,
DRG neurons extracted from L5 and L6 of 2 SNL rats were sepa-
rated according to their size, as described in Materials and Meth-
ods. The LDF was enriched in smaller neurons, while the HDF
was enriched in larger neurons (Fig. 4A). The mean diameter for
neurons in the LDF was 10.0 ± 0.2 lm (n = 418), with a pronounced
peak at 5–10 lm. In the HDF, the smallest neurons (<15 lm in
diameter) were almost absent, and the neuron diameter was up
to 50 lm, with a peak at 21–25 lm. The mean diameter was
24.5 ± 0.7 lm (n = 260). As expected, NF-200 mRNA, a marker for
large myelinated DRG neurons [42], measured by CE/LIF, was sig-niﬁcantly higher in the HDF (13.9 ± 3.8 arbitrary units (AU)) com-
pared to the LDF (1.8 ± 0.4 AU) (Fig. 4B), conﬁrming that the HDF
contains mainly larger neurons expressing NF-200.
We then used RT-PCR and CE/LIF to quantify the relative abun-
dance of a2d-1 DA+B+C and DA+BDC in the small and large DRG
neuron fractions after SNL. In agreement with the previous exper-
iments, both DA+B+C (Fig. 4C) and DA+BDC (Fig. 4D) transcript
levels were signiﬁcantly increased on the ipsilateral side compared
to the contralateral side after SNL. We further analysed whether
the differential upregulation of DA+BDC compared to DA+B+C
mRNA found in whole DRG (Fig. 3E) was present in both small
and large neuron fractions. This was calculated as the percentage
increase on the ipsilateral compared to the contralateral side, of
the 2 transcripts in the small neuron fraction (white bars) com-
pared to the large neuron fraction (grey bars). This analysis was
performed to provide a direct comparison with the values found
in whole DRG (Fig. 3C, D). We found that the increase of DA+BDC
mRNA following SNL was signiﬁcantly greater compared to the
corresponding DA+B+C increase, only in the small neuron fraction,
and not in the large neuron fraction (Fig. 4E).
Thus, although upregulation following SNL of the 2 DRG tran-
scripts DA+B+C and DA+BDC occurs in both small and large DRG
neurons (Fig. 4C, D), the increased upregulation of DA+BDC com-
pared to DA+B+C following SNL occurs preferentially in the small
DRG neuron fraction containing nonmyelinated nociceptors
(Fig. 4E).
3.6. Electrophysiological properties of the 2 splice variants present in
DRG
It was important to determine whether a2d-1 DA+BDC was a
functional splice variant, and we therefore compared the proper-
ties of CaV2.2 calcium channel currents co-expressed with b1b
and either a2d-1 DA+BDC or DA+B+C. CaV2.2 was used because it
is the main calcium channel in DRG neurons. We found that the
properties of the currents formed from these combinations were
very similar in terms of their ability to increase CaV2.2 current den-
sity compared to the absence of a2d (Fig. 5A–C), their ability to in-
crease the inactivation rate of the currents (Fig. 5D, E), and their
ability to hyperpolarize the steady-state inactivation of the cur-
rents (Fig. 5F). Since CaV2.1 is also present in DRG neurons, we also
examined calcium currents formed by this channel. Similar results
were obtained, in terms of the effect of the a2d-1 splice variants on
current amplitude (Supplementary Fig. 2A–C), voltage-dependence
of inactivation (Supplementary Fig. 2D), and kinetics of inactiva-
tion (Supplementary Fig. 2E).4. Discussion
4.1. Genomic arrangement of a2d-1 giving rise to splice variants
The cacna2d1 gene encoding mouse a2d-1 was found to contain
3 alternatively spliced regions within the a2 moiety (A, B, and C)
[3]. It was originally reported that regions A and B were part of
the same exon, with alternative 30 splice acceptor site, which
spliced region A in or out [3]. In this scenario, splice variants of
a2d-1 should not exist in which region A is expressed without B.
However, our analysis of the mouse genomic sequence has found
that A is encoded by exon 18a, and B is formed as a result of utiliz-
ing an alternative 30 splice acceptor site for exon 19. In conﬁrma-
tion of this, we have found splice variants in rat heart in which A
is expressed without B (Fig. 1C).
In skeletal muscle, a2d-1 +A+BDC was the only splice variant
detected [3]. We did not identify any minor splice variants in skel-
etal muscle in our study. We also found that the +A+BDC splice
Fig. 4. Analysis of the upregulation of DA+B+C and DA+BDC in small and large dorsal root ganglion (DRG) neurons following spinal nerve ligation (SNL). (A) DRG neurons
were separated into 2 populations (high-density fraction [HDF] and low-density fraction [LDF]) on the basis of size, by centrifugation through a Ficoll density gradient. The
proportion of neurons as function of diameter in the fraction enriched in smaller neurons (LDF; white bars) and larger neurons (HDF; grey bars) is shown. Data are from 4
separate cultures obtained from the extraction of L5 and L6 DRG neurons from 2 naïve adult rats. When the same separation of DRG neurons was performed on SNL rats, all
the material was used to extract the RNA, for use in capillary electrophoresis/laser-induced ﬂuorescence (CE/LIF) experiments. A total of 418 cells from the LDF and 260 cells
from the HDF were analysed. Error bars represent SEM. (B) Neuroﬁlament-200 (NF-200) mRNA levels measured by CE/LIF are signiﬁcantly higher in the HDF compared to the
LDF. Data are expressed as NF-200 relative peak areas in the LDF (white bar, n = 4) and HDF (grey bar, n = 4). Error bars represent SEM. Statistical analysis was performed
using an unpaired Student’s t-test, ⁄P = 0.0187. (C, D) Transcript levels of a2d-1 DA+B+C (C, n = 7) and DA+BDC (D, n = 6) in small and large DRG neuron fractions prepared
from L5/L6 DRG, ipsilateral and contralateral to SNL. Data are expressed as DA+B+C or DA+BDC relative peak areas. Transcript levels in small (white bars) or large (grey bars)
DRG neurons prepared from L5/L6 DRG, both contralateral (hatched bars) and ipsilateral (solid bars) to SNL. DA+B+C and DA+BDC transcript levels were signiﬁcantly higher
on the ipsilateral side compared to the contralateral side in both the small neurons (4.0 ± 0.6-fold for DA+B+C and 9.2 ± 2.4-fold for DA+BDC), and in the large neurons
(4.0 ± 0.7-fold for DA+B+C and 7.4 ± 2.4-fold forDA+BDC). Error bars represent SEM. Statistical analyses were performed using 2 sample unpaired Student’s t-test, for the data
indicated. (E) Comparison of the upregulation in ipsilateral compared to contralateral L5 and L6 DRG of the 2 DRG a2d-1 transcripts, 7 days after SNL. In the small neuron
fraction (white bars), the extent of upregulation of DA+BDC (right, n = 6) is signiﬁcantly greater than that of DA+B+C (left, n = 7). In contrast, there is no signiﬁcant difference
between the upregulation of the 2 transcripts in the large neuron fraction (grey bars). Data are expressed as relative peak areas for the ipsilateral side normalized to the
respective contralateral side. Error bars represent SEM. Statistical analyses were performed using unpaired Student’s t-test.
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previous ﬁndings of high-afﬁnity binding of 3H-gabapentin to na-
tive rat skeletal muscle a2d-1 [27]. Our results conﬁrm that the
lack of effect of gabapentin on skeletal muscle function is not a re-
sult of its inability to bind to the skeletal muscle a2d-1 isoform.In mouse heart, a2d-1 DADB+C was previously found to be the
most prevalent splice variant, although other splice variants were
also observed, speciﬁcally DA+B+C, DADBDC, and DA+BDC [3]. In
this study we found that DADBDC was the predominant isoform
in rat heart tissue, but we also found 6 other splice variants
Fig. 5. Comparison of the effect of the 2 main dorsal root ganglion a2d-1 splice variants on CaV2.2 calcium channel current properties. (A) Representative current traces
elicited between 30 and +40 mV in 10-mV voltage steps from a holding potential of 90 mV for CaV2.2/b1b, co-expressed in tsA-201 cells either without a2d (left, j), or
with a2d-1 DA+B+C (middle, d) or a2d-1 DA+BDC (right, D). 1 mM Ba2+ was used as the charge carrier. (B) Current-voltage (I-V) relationships for the 3 experimental
conditions: CaV2.2/b1b/ a2d-1 DA+B+C (d, n = 16), CaV2.2/b1b/ a2d-1 DA+BDC (D, n = 20), or CaV2.2/b1b (j, n = 12). Current amplitude was normalized to whole-cell
capacitance and plotted against membrane potential. Data are ﬁtted using a modiﬁed Bolzmann function, as previously described [12]. (C) Peak current density was
103.56 ± 13.9 pA/pF in presence of DA+B+C (black bar) and 116.63 ± 13.9 pA/pF in presence of DA+BDC (grey bar). These values were both signiﬁcantly higher than the
current density measured in the absence of a2d-1, which was 9.6 ± 2 pA/pF (white bar). Error bars represent SEM. Statistical analysis was performed using 1-way analysis of
variance (ANOVA) and Bonferroni post hoc analysis, ⁄⁄⁄ denotes P < 0.001). (D) Representative current traces in response to a long depolarizing voltage step (0.9 second) to
0 mV for CaV 2.2/b1b, co-expressed in tsA-201 cells either without a2d (left), or with a2d-1DA+B+C (middle) or a2d-1DA+BDC (right). 1 mM Ba2+ was used as a charge carrier.
Holding potential was 90 mV. Traces are normalized to their peak. (E) a2d-1 DA+B+C and DA+BDC signiﬁcantly accelerated the inactivation of currents compared to no a2d.
The decay phase of individual current traces at 0 mV was ﬁtted with a single exponential function, and the mean time constant (s) of inactivation was 204.3 ± 10.3 ms for
DA+B+C (black bar, n = 10), 186.4 ± 15.8 ms for DA+BDC (grey bar, n = 14), and 248.0 ± 23.6 ms for CaV2.2/b1b without a2d (white bar, n = 10). Statistical analyses were
performed using 1-way ANOVA, Bonferroni post hoc analysis, ⁄P < 0.05. (F) Steady-state inactivation curves for IBa evoked by a test pulse to +20 mV after a 10-second
conditioning prepulse of between 100 and 0 mV. CaV2.2/b1b/a2d-1 DA+B+C (d, n = 15), CaV2.2/ b1b/a2d-1 DA+BDC (D, n = 13), CaV2.2/ b1b (j, n = 10). Error bars represent
SEM. Data were ﬁtted with a single Boltzmann equation, and the mean voltages at which the channel is 50% inactivated were 61.3 ± 1.2 mV, 60.0 ± 1.9 mV, and
50.7 ± 1.9 mV, respectively.
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155 (2014) 522–533 531(Fig. 1C). It is of interest to note that theDADBDC splice variant has
a signiﬁcantly lower afﬁnity for 3H-gabapentin, compared to the
major brain splice variant (Fig. 2). This result correlates with an
early ﬁnding that the speciﬁc binding of 3H-gabapentin to heart
membranes is lower than that in brain membranes, although this
may additionally represent a smaller number of binding sites
[27]. In brain, the only splice variant found previously was DA+B+C
[3], and its presence was conﬁrmed in our study. We found that
this was also the main splice variant in DRG neurons.
4.2. Differential upregulation of the minor a2d-1 splice variant in DRG
after SNL
Following SNL in rats, we found previously that the level of a2d-
1 mRNA was increased >500% in L5/L6 DRG neurons, ipsilateral
compared to contralateral to the ligation, and this was accompa-
nied by a similar increase in a2d-1 protein [5]. We conﬁrmed that
result here, for the main splice variant DA+B+C, where a 3.6-fold
increase was observed. However, by CE/LIF we were also able to
observe the presence in DRG of a second, minor splice variant
DA+BDC, whose level was increased over 10-fold following SNL.
Therefore, this splice variant, which has a lower binding afﬁnity
for 3H-gabapentin, was differentially upregulated in SNL. In the
experiments described here, DA+BDC increased from 5.1% of the
total transcript in sham-operated L5 DRG to 8.4% in L5 ipsilateral
to SNL.
4.3. Involvement of spliced regions of a2d-1 in 3H-gabapentin binding
To date, several sites in a2d-1 have been established to be
important for its ability to bind gabapentin [9,50]. The triple argi-
nine motif, situated just upstream of the VWA domain in a2d-1, is
essential for high-afﬁnity 3H-gabapentin binding, and also for the
ability of gabapentin to alleviate hyperalgesia [24], and to inhibit
calcium currents when applied chronically [30]. One of the other
regions identiﬁed by Wang et al. [50] is located just downstream
of region B, and another is just upstream of region C.
In the present study, we found that both the DA+BDC and
DADBDC splice variants possessed signiﬁcantly lower afﬁnity for
3H-gabapentin, compared to the other splice variants tested. How-
ever, there was no signiﬁcant difference in the gabapentin binding
afﬁnity to a2d-1 +A+B+C, containing region A, compared to its ab-
sence in DA+B+C. Similarly, for the presence or absence of region
B, the 3H-gabapentin binding afﬁnity was similar for a2d-1DA+B+C
and DADB+C. These data indicate that A and B are not directly in-
volved in the binding of gabapentin. This suggests that it is primar-
ily the absence of region C in a2d-1 DA+BDC and DADBDC that is
critical for the reduced 3H-gabapentin binding afﬁnity of these 2
splice variants. The sequence of region C in rat a2d-1 is SKKGKMK,
which is positively charged, as is the triple arginine motif that is
essential for 3H-gabapentin binding.
It is notable that the afﬁnity of gabapentin for a2d-1 is much
greater (ie, a lower KD) than the clinically relevant concentrations.
One potential factor contributing to this discrepancy is that an
endogenous ligand may occupy the gabapentin-binding site on
a2d-1 in vivo, and compete with gabapentin. This also accounts
for the ﬁnding that puriﬁcation of the a2d proteins results in a
marked increase in apparent afﬁnity for gabapentin, as the endog-
enous ligand is removed during puriﬁcation [8,18].
4.4. Efﬁcacy of gabapentin following SNL
It has been demonstrated that the effect of gabapentin is state
dependent, in that in most circumstances it is able to inhibit neu-
ropathic pain responses in experimental animals, while having no
effect on physiological nociception [14,24,25,41]. Alterations ingene expression occur following neuropathic nerve damage, which
lead to changes in primary afferent inputs into the spinal cord,
including the upregulation of a2d-1 in these terminals [5]. It has
been demonstrated that gabapentin blocks calcium currents
acutely in DRG from mice overexpressing a2d-1, but not in control
animals [36], and this model may mimic the neuropathic condi-
tion. Our results indicate that the upregulation of speciﬁc splice
variants of a2d-1 in SNL does not contribute to determining the
state dependence of the efﬁcacy of gabapentin, since no splice vari-
ants with an increased afﬁnity for gabapentin were identiﬁed in
DRG neurons following SNL. Thus, the state dependence of gaba-
pentin is likely to depend on the overall elevation of all a2d-1 splice
variants.
4.5. Biophysical properties of a2d-1 splice variants found in DRG
It is thought that increased presynaptic calcium currents,
resulting from the upregulation of a2d-1, contribute to the hyper-
excitability of DRG that underlies hyperalgesia and allodynia
[36]. If the alternative splicing of a2d-1 were to modify the electro-
physiological properties of a2d-1-containing channels, the conse-
quences of altered function would be augmented following
differential upregulation of the a2d-1 DA+BDC splice variant, as a
consequence of nerve damage. However, we have demonstrated
here that the ability of a2d-1 DA+BDC to elicit calcium currents
is not affected by deletion of region C. a2d-1DA+BDC enhances cal-
cium currents resulting from the co-expression with either CaV2.2
or CaV2.1 to the same extent as a2d-1 DA+B+C. This result indicates
that the differential upregulation of a2d-1DA+BDC in DRG neurons
does not contribute to triggering hyperexcitability to a greater ex-
tent than the main DRG splice variant.
4.6. Changes in calcium channel splicing following sensory nerve
damage
It is of interest to compare our results with those for the exon
37a variant of CaV2.2, which is selectively expressed in DRG neu-
rons, and conducts larger calcium currents than the exon 37b var-
iant [1,6]. Despite being present overall at 7% of the main splice
variant 37b of CaV2.2, it was found selectively in small DRG neu-
rons also expressing VR1 [1,6]. Interestingly, the 37a splice variant
was downregulated to 2% in DRG following SNL [1], whereas
there was no change in the main CaV2.2 splice variant containing
exon 37b.
In contrast, in our study there was a greater increase of a2d-1
DA+BDC compared to the main splice variant a2d-1 DA+B+C fol-
lowing SNL, and this differential increase occurred particularly in
the nonmyelinated small DRG neuron fraction. This, together with
our ﬁnding that DA+BDC had a signiﬁcantly lower afﬁnity for
gabapentin, and an equivalent ability to enhance neuronal calcium
currents, could be highly relevant to the response to gabapentin in
patients with chronic neuropathic pain. The rat a2d-1 DA+BDC
mRNA sequence used in this study has 95% amino acid homology
with the human sequence, and C region is identical in both species.
Therefore, it is reasonable to speculate that human a2d-1 DA+BDC
(accession number P54289 isoform 5) is expressed in DRG neurons
and undergoes similar upregulation in conditions leading to the
development of chronic neuropathic pain. It is, further, tempting
to speculate that differences in the extent of upregulation of a2d-
1 DA+BDC in humans could potentially contribute to the variable
efﬁcacy of gabapentinoid drugs [37,38].
4.7. Conclusion
We have identiﬁed a novel a2d-1 splice variant DA+BDC, which
is expressed in DRG neurons and is differentially upregulated com-
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small nonmyelinated DRG neurons following SNL. This splice vari-
ant supports CaV2 calcium currents with unaltered properties, but
shows a signiﬁcantly reduced afﬁnity for gabapentin. It could
therefore play a role in determining the efﬁcacy of gabapentin in
different forms of neuropathic pain. Furthermore, targeting this
splice variant for drug discovery could increase the therapeutic
efﬁcacy of gabapentinoid drugs in the future.
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